1-12 of 12
Yong Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A12: Quercetin inhibits multiple pathways involved in interleukin 6 secretion from human lung fibroblasts and activity in bronchial epithelial cell transformation induced by benzo[a]pyrene diol epoxide

Wenshu Chen, Mabel T. Padilla, Xuling Xu, Dhimant Desai, Jacek Krzeminski, Shantu Amin, Yong Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1_Supplement): A12.
https://doi.org/10.1158/1557-3265.PMCCAVULN16-A12
Published: 02 January 2017
View article titled, Abstract A12: Quercetin inhibits multiple pathways involved in interleukin 6 secretion from human lung fibroblasts and activity in bronchial epithelial cell transformation induced by benzo[a]pyrene diol epoxide
Journal Articles

Abstract A06: Combination of TRAIL and Chal-24 synergistically induces autophagy-mediated apoptosis in lung cancer cells

Xiuling Xu, Jennings Xu, Shaoqing Shi, Qiong Wang, Bryanna Saxton, Chengguo Xing, Yong Lin
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1_Supplement): A06.
https://doi.org/10.1158/1557-3265.PMCCAVULN16-A06
Published: 02 January 2017
View article titled, Abstract A06: Combination of TRAIL and Chal-24 synergistically induces autophagy-mediated apoptosis in lung cancer cells
Journal Articles

Nuclear Factor-κB Modulation in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia

Roger K. Strair, Mecide Gharibo, Dale Schaar, Arnold Rubin, Jonathan Harrison, Joseph Aisner, Hsin-Ching Lin, Yong Lin, Lauri Goodell, Monika Anand, Binaifer Balsara, Liesel Dudek, Arnold Rabson, Daniel J. Medina
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (22): 7564–7568.
https://doi.org/10.1158/1078-0432.CCR-08-1390
Published: 14 November 2008
View article titled, Nuclear Factor-κB Modulation in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
Open the PDF for Nuclear Factor-κB Modulation in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia in another window
Journal Articles

Synergistic Inhibition of Lung Tumorigenesis by a Combination of Green Tea Polyphenols and Atorvastatin

Gang Lu, Hang Xiao, Hui You, Yong Lin, Huanyu Jin, Blake Snagaski, Chung S. Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4981–4988.
https://doi.org/10.1158/1078-0432.CCR-07-1860
Published: 01 August 2008
View article titled, Synergistic Inhibition of Lung Tumorigenesis by a Combination of Green Tea Polyphenols and Atorvastatin
Open the PDF for Synergistic Inhibition of Lung Tumorigenesis by a Combination of Green Tea Polyphenols and Atorvastatin in another window
Journal Articles

Phase I and Pharmacokinetic Study of Imatinib Mesylate (Gleevec) and Gemcitabine in Patients with Refractory Solid Tumors

Yaqoob Ali, Yong Lin, Mecide M. Gharibo, Murugesan K. Gounder, Mark N. Stein, Theodore F. Lagattuta, Merrill J. Egorin, Eric H. Rubin, Elizabeth A. Poplin
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5876–5882.
https://doi.org/10.1158/1078-0432.CCR-07-0883
Published: 01 October 2007
View article titled, Phase I and Pharmacokinetic Study of Imatinib Mesylate (Gleevec) and Gemcitabine in Patients with Refractory Solid Tumors
Open the PDF for Phase I and Pharmacokinetic Study of Imatinib Mesylate (Gleevec) and Gemcitabine in Patients with Refractory Solid Tumors in another window
Journal Articles

Atorvastatin and Celecoxib Inhibit Prostate PC-3 Tumors in Immunodeficient Mice

Xi Zheng, Xiao-Xing Cui, Gina E. Avila, Mou-Tuan Huang, Yue Liu, Jagruti Patel, Ah Ng Tony Kong, Raphael Paulino, Weichung Joe Shih, Yong Lin, Arnold B. Rabson, Bandaru S. Reddy, Allan H. Conney
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5480–5487.
https://doi.org/10.1158/1078-0432.CCR-07-0242
Published: 17 September 2007
View article titled, Atorvastatin and Celecoxib Inhibit Prostate PC-3 Tumors in Immunodeficient Mice
Open the PDF for Atorvastatin and Celecoxib Inhibit Prostate PC-3 Tumors in Immunodeficient Mice in another window
Journal Articles

Effects of 12-O-Tetradecanoylphorbol-13-acetate (TPA) in Combination with Paclitaxel (Taxol) on Prostate Cancer LNCaP Cells Cultured In vitro or Grown as Xenograft Tumors in Immunodeficient Mice

Xi Zheng, Richard L. Chang, Xiao-Xing Cui, Gina E. Avila, Vidya Hebbar, Mark Garzotto, Weichung Joe Shih, Yong Lin, Shou-En Lu, Arnold B. Rabson, Ah Ng Tony Kong, Allan H. Conney
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (11): 3444–3451.
https://doi.org/10.1158/1078-0432.CCR-05-2823
Published: 01 June 2006
View article titled, Effects of 12-<em>O</em>-Tetradecanoylphorbol-13-acetate (TPA) in Combination with Paclitaxel (Taxol) on Prostate Cancer LNCaP Cells Cultured <em>In vitro</em> or Grown as Xenograft Tumors in Immunodeficient Mice
Open the PDF for Effects of 12-<em>O</em>-Tetradecanoylphorbol-13-acetate (TPA) in Combination with Paclitaxel (Taxol) on Prostate Cancer LNCaP Cells Cultured <em>In vitro</em> or Grown as Xenograft Tumors in Immunodeficient Mice in another window
Journal Articles

Overexpression of 5-Lipoxygenase in Rat and Human Esophageal Adenocarcinoma and Inhibitory Effects of Zileuton and Celecoxib on Carcinogenesis

Xiaoxin Chen, Su Wang, Nan Wu, Sandeep Sood, Peng Wang, Zhe Jin, David G. Beer, Thomas J. Giordano, Yong Lin, Wei-chung J. Shih, Ronald A. Lubet, Chung S. Yang
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6703–6709.
https://doi.org/10.1158/1078-0432.CCR-04-0838
Published: 08 October 2004
View article titled, Overexpression of 5-Lipoxygenase in Rat and Human Esophageal Adenocarcinoma and Inhibitory Effects of Zileuton and Celecoxib on Carcinogenesis
Open the PDF for Overexpression of 5-Lipoxygenase in Rat and Human Esophageal Adenocarcinoma and Inhibitory Effects of Zileuton and Celecoxib on Carcinogenesis in another window
Journal Articles

Expression Genomics of Cervical Cancer: Molecular Classification and Prediction of Radiotherapy Response by DNA Microarray

Yick Fu Wong, Zachariah E. Selvanayagam, Nien Wei, Joseph Porter, Ragini Vittal, Rong Hu, Yong Lin, Jason Liao, Joe Weichung Shih, Tak Hong Cheung, Keith Wing Kit Lo, So Fan Yim, Shing Kai Yip, Danny Tse Ngong, Nelson Siu, Loucia Kit Ying Chan, Chun Sing Chan, Tony Kong, Elena Kutlina, Randall D. McKinnon, David T. Denhardt, Khew-Voon Chin, Tony Kwok Hung Chung
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (15): 5486–5492.
Published: 03 December 2003
View article titled, Expression Genomics of Cervical Cancer: <subtitle>Molecular Classification and Prediction of Radiotherapy Response by DNA Microarray</subtitle>
Open the PDF for Expression Genomics of Cervical Cancer: <subtitle>Molecular Classification and Prediction of Radiotherapy Response by DNA Microarray</subtitle> in another window
Journal Articles

Phase I Evaluation of Sequential Topoisomerase Targeting with Irinotecan/Cisplatin Followed by Etoposide in Patients with Advanced Malignancy

Edward J. Licitra, Viral Vyas, Kathy Nelson, Rita Musanti, Stephanie Beers, Cecilia Thomas, Elizabeth Poplin, Sharon Smith, Yong Lin, Larry. J. Schaaf, Joseph Aisner, Murugesan Gounder, Rajeev Rajendra, Ahamed Saleem, Deborah Toppmeyer, Eric H. Rubin
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (5): 1673–1679.
Published: 01 May 2003
View article titled, Phase I Evaluation of Sequential Topoisomerase Targeting with Irinotecan/Cisplatin Followed by Etoposide in Patients with Advanced Malignancy
Open the PDF for Phase I Evaluation of Sequential Topoisomerase Targeting with Irinotecan/Cisplatin Followed by Etoposide in Patients with Advanced Malignancy in another window
Journal Articles

A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies

Eric H. Rubin, Dinesh P. de Alwis, Isabelle Pouliquen, Lisa Green, Phil Marder, Yong Lin, Rita Musanti, Stephanie L. Grospe, Sharon L. Smith, Deborah L. Toppmeyer, Judy Much, Michael Kane, Ajai Chaudhary, Christopher Jordan, Michael Burgess, Christopher A. Slapak
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (12): 3710–3717.
Published: 01 December 2002
View article titled, A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies
Open the PDF for A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies in another window
Journal Articles

Expression of the Serine Protease Matriptase and Its Inhibitor HAI-1 in Epithelial Ovarian Cancer: Correlation with Clinical Outcome and Tumor Clinicopathological Parameters

Michael D. Oberst, Michael D. Johnson, Robert B. Dickson, Chen-Yong Lin, Baljit Singh, Moira Stewart, Alastair Williams, Awatif al-Nafussi, John F. Smyth, Hani Gabra, Grant C. Sellar
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1101–1107.
Published: 01 April 2002
View article titled, Expression of the Serine Protease Matriptase and Its Inhibitor HAI-1 in Epithelial Ovarian Cancer: <subtitle>Correlation with Clinical Outcome and Tumor Clinicopathological Parameters</subtitle>
Open the PDF for Expression of the Serine Protease Matriptase and Its Inhibitor HAI-1 in Epithelial Ovarian Cancer: <subtitle>Correlation with Clinical Outcome and Tumor Clinicopathological Parameters</subtitle> in another window